Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Bloomberg Television brings you the late...
Today, Chris Kennedy, Bloomberg Economic...
Comprehensive cross-platform coverage of...
Daniel Pilling, a portfolio manager at S...
Retired Gen. David Petraeus, former US C...
Michael Swanson, chief agriculture econo...
----------------------------------------...
Bloomberg’s Caroline Hyde and Ed Ludlow ...
Jay Ritter, University of Florida emerit...
As Wall Street is getting caught up in A...
----------------------------------------...
The rapid spread of AI across corporate ...
Qualcomm will supply chips to TikTok own...
Bloomberg Investigates spends a year fol...